KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Soundthinking (SSTI) Research & Development (2016 - 2025)

Soundthinking (SSTI) has disclosed Research & Development for 10 consecutive years, with $4.0 million as the latest value for Q4 2025.

  • Quarterly Research & Development rose 13.61% to $4.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.9 million through Dec 2025, up 13.94% year-over-year, with the annual reading at $15.9 million for FY2025, 13.94% up from the prior year.
  • Research & Development for Q4 2025 was $4.0 million at Soundthinking, down from $4.1 million in the prior quarter.
  • The five-year high for Research & Development was $4.1 million in Q3 2025, with the low at $1.7 million in Q3 2021.
  • Average Research & Development over 5 years is $2.9 million, with a median of $3.1 million recorded in 2023.
  • The sharpest move saw Research & Development skyrocketed 53.36% in 2022, then grew 0.99% in 2023.
  • Over 5 years, Research & Development stood at $1.9 million in 2021, then surged by 30.71% to $2.5 million in 2022, then skyrocketed by 32.0% to $3.2 million in 2023, then rose by 7.46% to $3.5 million in 2024, then increased by 13.61% to $4.0 million in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $4.0 million, $4.1 million, and $3.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.